Biocogniv Inc.

South Burlington, VT · Founded 2019 · Medtech · Acquired

AI-powered blood test for pulmonary embolism diagnosis using multiplex immunoassay biomarker analysis

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · biocogniv.com

Sector: Medtech
Headquarters: South Burlington, VT
Founded: 2019
Latest Form D: $10.7M, Oct 2023
Total capital: $11.3M

Federal grants: $510K; 2 awards · 2020; Rank in peer group#50 of 95
Private capital raised: $10.7M; 1 Form D · last Oct 2023; 36 months since last filing
Federal contracts: None on recordNo federal contract awards found.
Granted patents: 2; 2 pending · first 2023; Rank in peer group#11 of 95

Capital timeline

Latest events

Oct 2023Private capital raisedForm D · SEC · 1st filing$10.7M
Sep 2020Federal grantHealth and Human S · Phase I · Development of a Novel Diagnostic Test for Pulmonary Embolism Based on Artificial Intelligence and Spectral Analysis of Blood$300K
Jul 2020Federal grantNSF · Phase I · SBIR Phase I: Development of a Novel Diagnostic Test for Pulmonary Embolism Based on Artificial Intelligence and Spectral Analysis of Blood$210K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

39months

from Biocogniv Inc.’s first federal award to its first private round.

First federal award · Jul 2020: NSF · $210K
First Form D · Oct 2023: $10.7M · 1st Form D
Awards before first raise: 2 awards

An association in public records, not a cause or a prediction.

Standing among 95 peers

Line = median

Medtech · Instrument

Federal grantsBelow median
Granted patents#11 · top 12%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants

Artur AdibResearcherExecutive Officer, DirectorLinked by 1 patent · $210K in grants as PI
Tim WallDirectorNamed in SEC Form D filings

What it has protected

USPTO · 2 granted of 4

Jul 1, 2025GrantedDynamic Model Selection And Rule Based Data InterpretationUSPTOUS 12,346,829
May 22, 2025PendingMethod of Early Detection, Risk Stratification, and Outcomes Prediction of a Medical Disease or Condition with Machine Learning and Routinely Taken Patient DataUSPTOApplication 19027411
Sep 14, 2023PendingArtificial Intelligence Medical DeviceUSPTOApplication 18199031

Show all 4 patent records

Dynamic Model Selection And Rule Based Data InterpretationJul 1, 2025 · US 12,346,829Granted
Method of Early Detection, Risk Stratification, and Outcomes Prediction of a Medical Disease or Condition with Machine Learning and Routinely Taken Patient DataMay 22, 2025 · Application 19027411Pending
Artificial Intelligence Medical DeviceSep 14, 2023 · Application 18199031Pending
Method of Early Detection, Risk Stratification, and Outcomes Prediction of a Medical Disease or Condition with Machine Learning and Routinely Taken Patient DataJun 13, 2023 · US 11,676,722Granted

GEMSTONE BIOTHERAPEUTICS, LLCSimilar federal contract value in Medtech · null in contracts
ZENFLOW, INC.Similar federal contract value in Medtech · null in contracts
SIMPLYBREATHE L.L.C.Similar federal contract value in Medtech · null in contracts
FYR DIAGNOSTICS, INC.Similar federal contract value in Medtech · null in contracts
Mobile Sleep Technologies L.L.CSimilar federal contract value in Medtech · null in contracts
CONCENTRIS SYSTEMS LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.